Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
FLDM Fluidigm Corporation monthly Stock Chart
FLDM [NASD]
Fluidigm Corporation
Index- P/E- EPS (ttm)-1.80 Insider Own0.10% Shs Outstand28.79M Perf Week-3.43%
Market Cap186.56M Forward P/E- EPS next Y-1.88 Insider Trans-51.03% Shs Float28.65M Perf Month-32.29%
Income-51.40M PEG- EPS next Q-0.53 Inst Own- Short Float13.14% Perf Quarter-41.09%
Sales117.50M P/S1.59 EPS this Y-192.30% Inst Trans7.88% Short Ratio7.28 Perf Half Y-67.49%
Book/sh4.32 P/B1.50 EPS next Y3.60% ROA-13.10% Target Price14.64 Perf Year-83.28%
Cash/sh3.37 P/C1.92 EPS next 5Y-8.06% ROE-37.30% 52W Range4.84 - 46.38 Perf YTD-40.06%
Dividend- P/FCF- EPS past 5Y29.60% ROI-13.60% 52W High-86.03% Beta2.00
Dividend %- Quick Ratio4.60 Sales past 5Y35.60% Gross Margin60.20% 52W Low33.88% ATR0.89
Employees474 Current Ratio5.30 Sales Q/Q-3.40% Oper. Margin-39.40% RSI (14)35.94 Volatility13.80% 14.17%
OptionableYes Debt/Eq1.58 EPS Q/Q34.70% Profit Margin-43.70% Rel Volume1.69 Prev Close6.33
ShortableYes LT Debt/Eq1.58 EarningsFeb 04 AMC Payout- Avg Volume516.68K Price6.48
Recom2.00 SMA20-11.97% SMA50-29.38% SMA200-59.61% Volume871,230 Change2.37%
Jan-07-16Initiated Deutsche Bank Buy $18
Oct-30-15Upgrade Cantor Fitzgerald Hold → Buy $15 → $12
Oct-30-15Reiterated Mizuho Neutral $15 → $8
Aug-27-15Initiated Cantor Fitzgerald Hold
Aug-07-15Reiterated Mizuho Neutral $30 → $15
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
May-08-15Reiterated Maxim Group Buy $52 → $44
May-08-15Downgrade Mizuho Buy → Neutral $50 → $30
May-06-14Reiterated Maxim Group Buy $65 → $52
Apr-23-14Upgrade Mizuho Neutral → Buy $43 → $50
Mar-21-14Reiterated Maxim Group Buy $52 → $65
Feb-03-14Reiterated Oppenheimer Outperform $46 → $52
Jan-14-14Reiterated Mizuho Neutral $30 → $43
Dec-18-13Reiterated Maxim Group Buy $33 → $42
Oct-31-13Reiterated Mizuho Neutral $19 → $30
Oct-31-13Reiterated Maxim Group Buy $26 → $33
Aug-02-13Reiterated Mizuho Neutral $17 → $19
Aug-02-13Reiterated Maxim Group Buy $21 → $23
Jun-27-13Initiated Maxim Group Buy $21
Oct-09-12Downgrade Mizuho Buy → Neutral $17
Feb-05-16 06:02PM  Edited Transcript of FLDM earnings conference call or presentation 4-Feb-16 10:00pm GMT
Feb-04-16 04:55PM  Fluidigm reports 4Q loss
04:08PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:00PM  Fluidigm Announces Fourth Quarter and Full Year 2015 Financial Results GlobeNewswire
07:07AM  Q4 2015 Fluidigm Corp Earnings Release - After Market Close
Jan-28-16 06:30PM  FLUIDIGM TO ANNOUNCE Q4-FULL YEAR 2015 FINANCIAL RESULTS at noodls
05:30PM  Fluidigm to Announce Q4-Full Year 2015 Financial Results and Host Conference Call for Investors GlobeNewswire
Jan-19-16 01:40PM  Fluidigm's Q4 Preliminary Results Fail to Woo Investors -14.29%
Jan-15-16 01:10PM  Accuray Expands EIMEA Footprint with New Installations
Jan-12-16 08:17AM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:00AM  Fluidigm Announces Preliminary Full Year and Fourth Quarter 2015 Revenue GlobeNewswire
Jan-07-16 12:37PM  Coverage initiated on Fluidigm by Deutsche Bank
Dec-24-15 03:06PM  Fluidigm Mutes the Performance of IHIs Small Caps
Dec-23-15 02:10PM  At the Top of IHI, NxStage Extends Its Rally
08:00AM  Pre-market Insights on Healthcare Sector -- Fluidigm, AngioDynamics, Tandem Diabetes Care, and BioTelemetry Accesswire
Dec-16-15 04:59PM  The iShares US Medical Devices ETF (IHI) Has Put Nothing under the Tree in DecemberYet
Dec-14-15 04:07PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
07:55AM  Today's Market Driven by Key Factors - Free Research on Koppers Holdings, Dimension Therapeutics, Fluidigm and Orasure Technologies Accesswire
Dec-11-15 01:20PM  Fluidigm Now a Strong Buy on Portfolio & Pipeline Strength -6.21%
Dec-08-15 01:17PM  FLUIDIGM CORP Financials
Dec-02-15 09:20AM  Three Reasons Investors Should Consider Pressure BioSciences Accesswire -6.35%
08:56AM  Fluidigm (FLDM): Strong Industry, Solid Earnings Estimate Revisions
Dec-01-15 01:20PM  Allscripts Healthcare Announces New Share Buyback Worth $150M
Nov-30-15 02:05PM  Natus Medical (BABY) Hits 52-Week High on Solid Q3 Results +7.26%
01:20PM  Cardinal Health: Strong Buy on Strong Q1, Positive Outlook
08:54AM  Surging Earnings Estimates Signal Good News for Fluidigm (FLDM)
04:01AM  Do Hedge Funds Love Tokai Pharmaceuticals Inc (TKAI)? at Insider Monkey
Nov-27-15 01:40PM  Fluidigm's Juno on Time's 2015 Invention List, Shares Up
Nov-24-15 01:00PM  TIME Magazine Selects Fluidigms Juno system as One of the Best Inventions of 2015 Business Wire
09:00AM  Fluidigm to Present at Piper Jaffray 27th Annual Healthcare Conference Business Wire
Nov-21-15 02:29PM  Hedge Funds Are Yanking Their Capital Out Of Fluidigm Corporation (FLDM) at Insider Monkey
Nov-12-15 03:39PM  IHI Moves into the Red as Market Witnesses Weakness
02:16PM  6 Stocks to Watch -- 3 to Short and 3 to Buy at TheStreet
Nov-09-15 03:50PM  FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report
Nov-02-15 05:01PM  IHIs Bottom Ten Stocks Outperform Other Biotechnology ETFs +7.03%
04:59PM  IBB Was among the Best Biotechnology ETFs for the Week
02:13PM  4 Unusual-Volume Stocks Triggering Big Breakout Trades at TheStreet
06:45AM  How it All Plays Out - Research on Immersion, Nanometrics, Cohu and Fluidigm Accesswire
Oct-30-15 12:28PM  Why Fluidigm Corporation is Soaring Higher at Motley Fool +46.48%
Oct-29-15 11:13PM  Edited Transcript of FLDM earnings conference call or presentation 29-Oct-15 9:00pm GMT
05:00PM  Fluidigm Corp Earnings Call scheduled for 5:00 pm ET today
04:47PM  Fluidigm reports 3Q loss
04:29PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:00PM  Fluidigm Reports Q3 2015 Financial Results Business Wire
07:07AM  Q3 2015 Fluidigm Corp Earnings Release - After Market Close
Oct-21-15 09:00AM  Fluidigm to Announce Q3 2015 Financial Results and Host Conference Call for Investors Business Wire
Oct-07-15 04:51PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers
01:00PM  Becton, Dickinson Launches FACSseq Single Cell Sorter
Oct-01-15 10:30AM  Fluidigm Corp. Earnings Q2, 2015
Sep-03-15 05:00PM  Australias First Single-Cell Genomics Centre of Excellence Opens at Monash Health Translation Precinct Business Wire
Sep-02-15 04:12PM  FLUIDIGM CORP Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Aug-25-15 09:00AM  High Throughput Single-Cell mRNA Sequencing Preparation Comes to the Fluidigm C1 System Business Wire -5.46%
Aug-24-15 04:46PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
Aug-18-15 08:53AM  Weakness Seen in Fluidigm (FLDM) Estimates: Should You Stay Away?
Aug-13-15 08:10PM  10-Q for Fluidigm Corp. at Company Spotlight
Aug-10-15 07:58AM  FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report
Aug-07-15 02:17PM  Mid-Day Market Update: Friday's Movers, Jobs Report and Interest Rates -35.52%
01:35PM  Fluidigm Tumbles on Weak Earnings
12:06PM  Fluidigm (FLDM) Stock Plummeting After Earnings Results at TheStreet
09:26AM  Edited Transcript of FLDM earnings conference call or presentation 6-Aug-15 9:00pm GMT
Aug-06-15 05:21PM  Fluidigm reports 2Q loss
05:00PM  Fluidigm Corp Earnings Call scheduled for 5:00 pm ET today
04:15PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:00PM  Fluidigm Reports Q2 2015 Financial Results Business Wire
07:07AM  Q2 2015 Fluidigm Corp Earnings Release - After Market Close
Aug-04-15 04:50PM  FLUIDIGM CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jul-30-15 09:00AM  Fluidigm to Announce Q2 2015 Financial Results and Host Conference Call for Investors Business Wire
Jul-27-15 09:18AM  Illumina, Inc. Earnings Analysis: By the Numbers
Jul-23-15 09:16AM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers
Jul-14-15 02:05PM  Fluidigm (FLDM) and OpGen Extend Strategic Relationship - Analyst Blog
10:21AM  FLUIDIGM CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jul-13-15 12:00PM  Fluidigm and OpGen Enter Into Strategic Agreement to Develop Multi-Drug Resistance Testing Kits and Equipment GlobeNewswire
12:00PM  Fluidigm and OpGen Enter into Strategic Agreement to Develop Multi-Drug Resistance Testing Kits and Equipment Business Wire
Jun-25-15 02:35PM  Fluidigm's (FLDM) Callisto Now Available for Pre-Order - Analyst Blog
08:00AM  Fluidigm Introduces Advanced Mass Cytometry System Along With Sample Barcoding for Markedly Improved Discovery Workflows Business Wire
Jun-24-15 08:00AM  Fluidigm Revolutionizes In Vitro Modeling for Stem Cell Researchers and Cell Biologists Business Wire
Jun-22-15 01:20PM  Fluidigm's Single-Cell ATAC-seq Now Available to C1 Users - Analyst Blog
Jun-18-15 11:40AM  Single-Cell Epigenetics Comes to the Fluidigm C1 System Business Wire
Jun-04-15 09:40AM  Redmile Group returns an estimated 9.3% in May
Jun-03-15 09:00AM  Fluidigms JunoTM System Wins Gold at the 8th Annual International Design Awards Competition Business Wire
May-29-15 04:46PM  FLUIDIGM CORP Files SEC form 8-K, Shareholder Director Nominations, Other Events
May-28-15 04:45PM  Fluidigm Adds New Targeted Sequencing Application to Juno - Analyst Blog
May-27-15 09:00AM  Fluidigm Brings Automated Targeted Library Prep to Juno Business Wire
May-22-15 08:55AM  Weakness Seen in Fluidigm (FLDM) Estimates: Should You Stay Away? - Tale of the Tape
May-14-15 08:11PM  10-Q for Fluidigm Corp. at Company Spotlight
May-12-15 04:55PM  Fluidigm Q1 Revenues Lower than Expected, Stock Down - Analyst Blog
May-11-15 02:04PM  4 Breakout Stocks Spiking on Unusual Volume at TheStreet
09:46AM  FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report
May-08-15 12:13PM  Fluidigm (FLDM) Stock Falls on Earnings Miss at TheStreet -28.00%
May-07-15 06:10PM  Fluidigm reports 1Q loss
05:49PM  Thursday's After-Hours Movers: NeoPhotonics, Quality Distribution And More
05:00PM  Fluidigm Corp Earnings Call scheduled for 5:00 pm ET today
04:33PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Fluidigm Reports Q1 2015 Financial Results Business Wire
04:00PM  Fluidigm Appoints Steve McPhail General Manager of Production Genomics Business Business Wire
07:07AM  Q1 2015 Fluidigm Corp Earnings Release - After Market Close
May-04-15 10:50AM  Greatbatch (GB) Misses on Q1 Earnings, Sales; Shares Fall - Analyst Blog
Apr-30-15 09:00AM  Fluidigm to Announce Q1 2015 Financial Results and Host Conference Call for Investors Business Wire -5.57%
Apr-22-15 12:10PM  Thermo Fisher Q1 Earnings Top, Revenues Lag Estimates - Analyst Blog
Apr-16-15 11:50AM  Inogen Gains despite Further Delay in Form 10-K Filing - Analyst Blog
Fluidigm Corporation creates, manufactures, and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics. It provides various preparatory instruments, including C1 single-cell auto prep system, a sample preparation system that isolates, processes, and profiles individual cells for genomic analysis; and access array systems that enables automated polymerase chain reaction (PCR)-based target enrichment, barcoding, and tagging of resequencing libraries and facilitates parallel amplification. The company also offers analytical instruments comprising Biomark HD system, a PCR analytical instrument for gene expression analysis, single-cell targeted gene expression analysis, microRNA analysis, single nucleotide polymorphism (SNP) genotyping, and digital PCR; EP1 system that performs high-throughput SNP genotyping and end-point digital PCR; and CyTOF 2 system, a mass cytometry instrument that performs single-cell protein analysis by analyzing cells labeled with a panel of reagents conjugated to stable metal isotopes. In addition, it provides integrated fluidic circuits (IFCs), such as C1, access array, dynamic array, digital array, and flex six IFCs; assays and reagents consisting of Delta Gene and SNP type assays, access array target-specific primers, and Maxpar Reagents. Further, the company's products include juno systems and IFCs, callisto systems and IFCs, polaris systems and IFCs, and C1 mRNA Sequencing IFCs. It serves academic institutions; clinical laboratories; and pharmaceutical, biotechnology, and agricultural biotechnology companies. The company distributes its products through direct sales force and support organizations, distributors, or sales agents. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Worthington Gajus VincentPRESIDENT & CEONov 03Option Exercise4.086,00024,49712,815Nov 06 12:27 PM
Worthington Gajus VincentPRESIDENT & CEONov 03Sale11.506,00069,0246,815Nov 06 12:27 PM
Worthington Gajus VincentPRESIDENT & CEOOct 01Option Exercise4.086,00024,49712,815Oct 05 04:20 PM
Worthington Gajus VincentPRESIDENT & CEOOct 01Sale8.056,00048,2906,815Oct 05 04:20 PM
Worthington Gajus VincentPRESIDENT & CEOSep 02Option Exercise4.086,00024,49712,815Sep 03 08:00 PM
Worthington Gajus VincentPRESIDENT & CEOSep 02Sale11.236,00067,4086,815Sep 03 08:00 PM
Worthington Gajus VincentPRESIDENT & CEOSep 01Option Exercise4.136,00024,75712,815Sep 03 08:00 PM
Worthington Gajus VincentPRESIDENT & CEOSep 01Sale11.836,00070,9566,815Sep 03 08:00 PM
Worthington Gajus VincentPRESIDENT & CEOAug 11Option Exercise4.456,00026,67711,666Aug 13 08:00 PM
Worthington Gajus VincentPRESIDENT & CEOAug 11Sale12.876,00077,2285,666Aug 13 08:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERJun 16Option Exercise16.733,55059,3924,961Jun 18 07:57 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERJun 16Sale25.003,55088,7501,411Jun 18 07:57 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCJun 15Option Exercise8.373,00025,1204,389Jun 17 06:33 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCJun 15Sale24.203,00072,6001,389Jun 17 06:33 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERJun 10Option Exercise16.734006,6921,811Jun 12 06:52 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERJun 10Sale25.0040010,0001,411Jun 12 06:52 PM
Worthington Gajus VincentPRESIDENT & CEOJun 01Option Exercise4.456,00026,67711,666Jun 03 08:13 PM
Worthington Gajus VincentPRESIDENT & CEOJun 01Sale23.716,000142,2595,666Jun 03 08:13 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCMay 15Option Exercise6.413,00019,2173,922May 19 07:18 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCMay 15Sale25.263,00075,780922May 19 07:18 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERMay 12Option Exercise15.013,95059,2994,894May 14 08:20 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERMay 12Sale27.173,950107,322944May 14 08:20 PM
Worthington Gajus VincentPRESIDENT & CEOMay 01Option Exercise4.456,00026,67710,394May 05 07:08 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTMay 01Option Exercise14.783,00044,3453,947May 05 07:09 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTMay 01Sale37.363,000112,077947May 05 07:09 PM
Worthington Gajus VincentPRESIDENT & CEOMay 01Sale37.386,000224,2984,394May 05 07:08 PM
Yow Mai ChanSee RemarksApr 20Option Exercise15.4915,300236,99716,816Apr 22 05:14 PM
Yow Mai ChanSee RemarksApr 20Sale44.7315,300684,3061,516Apr 22 05:14 PM
Yow Mai ChanSee RemarksApr 17Option Exercise15.494,70072,8036,216Apr 21 05:12 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCApr 17Option Exercise4.453,00013,3383,922Apr 21 05:15 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCApr 17Sale43.053,000129,163922Apr 21 05:15 PM
Yow Mai ChanSee RemarksApr 17Sale44.044,700206,9881,516Apr 21 05:12 PM
Yow Mai ChanSee RemarksApr 08Option Exercise15.2630,000457,70531,516Apr 09 08:45 PM
Yow Mai ChanSee RemarksApr 08Sale42.6730,0001,280,0001,516Apr 09 08:45 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERApr 07Option Exercise14.603,95057,6704,894Apr 09 07:37 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERApr 07Sale40.813,950161,192944Apr 09 07:37 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTApr 01Option Exercise14.603,00043,8003,947Apr 03 07:15 PM
Worthington Gajus VincentPRESIDENT & CEOApr 01Option Exercise4.456,00026,67710,394Apr 03 07:15 PM
Worthington Gajus VincentPRESIDENT & CEOApr 01Sale40.026,000240,1004,394Apr 03 07:15 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTApr 01Sale41.633,000124,890947Apr 03 07:15 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCMar 16Option Exercise4.163,00012,4933,922Mar 18 08:08 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCMar 16Sale40.873,000122,610922Mar 18 08:08 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERMar 09Option Exercise14.603,95057,6704,894Mar 11 08:01 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERMar 09Sale41.483,950163,842944Mar 11 08:01 PM
Worthington Gajus VincentPRESIDENT & CEOMar 02Option Exercise4.456,00026,67710,394Mar 04 08:03 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTMar 02Option Exercise14.603,00043,8003,947Mar 04 08:04 PM
JONES EVAN/ FADirectorMar 02Sale44.157,500331,13364,451Mar 04 08:05 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTMar 02Sale43.783,000131,340947Mar 04 08:04 PM
Worthington Gajus VincentPRESIDENT & CEOMar 02Sale43.776,000262,6464,394Mar 04 08:03 PM
COLELLA SAMUEL DDirectorFeb 20Option Exercise4.455,70025,34325,373Feb 23 06:15 PM
COLELLA SAMUEL DDirectorFeb 20Sale38.925,700221,84919,673Feb 23 06:15 PM
COLELLA SAMUEL DDirectorFeb 19Option Exercise11.8938,840461,96158,513Feb 23 06:15 PM
COLELLA SAMUEL DDirectorFeb 19Sale38.9738,8401,513,72719,673Feb 23 06:15 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCFeb 18Option Exercise4.083,00012,2483,726Feb 20 06:11 PM
COLELLA SAMUEL DDirectorFeb 18Option Exercise16.008,800140,80028,473Feb 20 06:12 PM
COLELLA SAMUEL DDirectorFeb 18Sale38.718,800340,65919,673Feb 20 06:12 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCFeb 18Sale38.533,000115,590726Feb 20 06:11 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTFeb 11Option Exercise14.604,90071,5405,626Feb 13 07:41 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTFeb 11Sale37.624,900184,329726Feb 13 07:41 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERFeb 10Option Exercise14.983,95059,1852,974Feb 12 07:54 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERFeb 10Sale37.743,950149,065726Feb 12 07:54 PM